Predominately Black-Serving Hospitals Provide Poorer Care
07/19/2012, Health Services Research, Hospitals that mostly serve Black patients have worse mortality outcomes for both Black and White patients with three common conditions: heart attack, congestive heart failure or pneumonia. The new study in Health Services Research suggests that there is an urgent need to improve care at predominately black-serving institutions. (Source: Health Behavior News Service)
Source: Health Behavior News Service - February 6, 2013 Category: Consumer Health News Source Type: news

Doctors Who Share Patients May Provide Lower Cost Care
07/31/2012, Journal of General Internal Medicine, Patients with diabetes or congestive heart failure who receive care from doctors with high levels of patient overlap have lower total health care costs and lower rates of hospitalization, according to a new study in the Journal of General Internal Medicine. (Source: Health Behavior News Service)
Source: Health Behavior News Service - February 6, 2013 Category: Consumer Health News Source Type: news

Give your heart a valentine: Pretty, red Hawthorn berries boost cardiac health
There is a health craze that is good for the heart and it's called the red Hawthorn berries. Hawthorn berries (Crateagus oxycanthus) boosts cardiac health aside from preventing cardiac arrhythmia, congestive heart failure, high blood pressure and angina. Having been... (Source: NaturalNews.com)
Source: NaturalNews.com - February 6, 2013 Category: Consumer Health News Source Type: news

Boston Doctors Use ‘Medical GPS’ To Help In Heart Surgeries
var WNVideoCanvas_vid8327388 = new WNVideoWidget("WNVideoCanvas", "WNVideoCanvas_vid8327388", "1"); //Playback options WNVideoCanvas_vid8327388.SetVariable("widgetId", 8327388); WNVideoCanvas_vid8327388.SetVariable("addThisDivId", "WNVideoCanvas_vid8327388_addThis"); WNVideoCanvas_vid8327388.SetVariable("incanvasAdDivId", "WNVideoCanvas_vid8327388_adDiv"); WNVideoCanvas_vid8327388.SetVariable("clipId", "8327388"); WNVideoCanvas_vid8327388.SetVariable("isMute", "false"); WNVideoCanvas_vid8327388.Set...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - February 6, 2013 Category: Consumer Health News Authors: deanreddington Tags: Health Local News Seen On WBZ-TV Syndicated Local Watch Listen Atrial Fibrillation GPS Heart Surgery Kerry Connolly Mediguide Source Type: news

National utilization patterns of warfarin use in older patients with atrial fibrillation: a population-based study of Medicare Part D beneficiaries
Source: Annals of Pharmacotherapy Area: Evidence> Medicines Management> References Background: Although warfarin therapy reduces stroke incidence in patients with atrial fibrillation (AF), the rate of warfarin use in this population remains low.  In 2008, the US Medicare Part D programme was expanded to pay for medications for Medicare enrollees. Objective: To examine rates and predictors of warfarin use in Medicare Part D beneficiaries with AF. Methods: This population-based retrospective cohort study used claims data from 41,447 Medicare beneficiaries aged 66 and older with at least 2 AF diagnoses in 2007...
Source: NeLM - Cardiovascular Medicine - January 24, 2013 Category: Cardiology Source Type: news

RCTs: Peginesatide in patients with anaemia and chronic kidney disease
Source: N Engl J Med Area: News In the New England Journal of Medicine, researchers report the results of four event-driven, randomised, controlled, open-label trials that compared the efficacy and safety of standard erythropoiesis-stimulating agent (ESA) therapy with peginesatide (Omontys), a peptide based ESA approved in the US in March 2012 for the treatment of anaemia caused by chronic kidney disease in adults who are undergoing dialysis.   The EMERALD 1 and EMERALD 2 studies involved patients undergoing haemodialysis. Cardiovascular safety was evaluated by analysis of an adjudicated composite safety end poin...
Source: NeLM - News - January 24, 2013 Category: Drugs & Pharmacology Source Type: news

Report: About 300K patients were remotely monitored in 2012
Last year healthcare providers remotely monitored about 308,000 patients worldwide for congestive heart failure (CHF), chronic obstructive pulmonary disease (COPD), diabetes, hypertension and mental health conditions, according to a recent report from InMedica. By 2017 that number should spike to 1.8 million patients, the research firm predicts. InMedica found that the majority of patients are being [...] (Source: mobihealthnews)
Source: mobihealthnews - January 22, 2013 Category: Information Technology Authors: Brian Dolan Tags: Uncategorized Berg Insight chronic condition management congestive heart failure COPD Diabetes digital health metrics hypertension IHS IMS Research InMedica mental health mobile health metrics remote patient monitoring Source Type: news

Differences and time trends in drug treatment of atrial fibrillation in men and women and doctors' adherence to warfarin therapy recommendations
Source: European Journal of Clinical Pharmacology Area: Evidence> Medicines Management> References Background: Little is known about prescription trends in atrial fibrillation (AF) in primary health care in Sweden. Objective: The aim was to study time trends in pharmacotherapy, in men and women with AF.  We also aimed at studying doctors' adherence to CHADS2 for prescribing warfarin.  CHADS2 assesses stroke risk by presence of known risk factors, i.e. congestive heart failure, hypertension, age over 75 years, diabetes, previous stroke and transient ischaemic attack. Methods: Data were obtained from pri...
Source: NeLM - Cardiovascular Medicine - January 18, 2013 Category: Cardiology Source Type: news

Phase III trial of darbepoetin alfa (Aranesp) in heart failure fails to meet primary efficacy endpoint
Source: PharmaLive Area: News Amgen has announced that its phase III Aranesp® (darbepoetin alfa) RED-HF® (Reduction of Events With Darbepoetin Alfa in Heart Failure) trial has failed to meet its primary efficacy endpoint.   The trial was initiated in 2006, and recruited 2278 patients with symptomatic systolic heart failure and anaemia (haemoglobin 9.0 to 12.0 g/dL) who were randomised to receive either treatment with darbepoetin to achieve a target haemoglobin of at least 13.0 g/dL (not to exceed 14.5 g/dL), or placebo. The study primary endpoint was a reduction in the composite endpoint of time to death ...
Source: NeLM - Cardiovascular Medicine - January 17, 2013 Category: Cardiology Source Type: news

REVIVE-IT study to examine earlier device use for patients with heart failure
(University of Michigan Health System) Left ventricular assist devices are usually only available as a last resort for patients with congestive heart failure, but a new study will examine the benefits of using heart devices before patients reach late-stage heart failure. Researchers at the University of Michigan Cardiovascular Center and University of Pittsburgh will evaluate whether technology now reserved for very sick patients is ready for use for a broader group of patients in need. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 14, 2013 Category: Global & Universal Source Type: news

Summaries: International Kidney Cancer Symposium
Conclusion: there is no increased risk of doing the lymph node dissection early on.   Dr. Eggener-CON   Basics Lymph node dissections rarely done, even for large tumors, because there is no proven therapeutic or staging benefit for low risk patients.  A Mayo study revealed no data showing therapeutic benefit in high risk patients.  For clinically node negative high risk patients, there is staging value but no proven therapeutic benefit. Rate of positive nodes is associated with stage and grade; the higher the stage and grade, the more likely there will be positive nod...
Source: Kidney Cancer Association - November 29, 2011 Category: Urology & Nephrology Source Type: news

Summaries: International Kidney Cancer Symposium
Conclusion: there is no increased risk of doing the lymph node dissection early on. Dr. Eggener-CON  Basics Lymph node dissections rarely done, even for large tumors, because there is no proven therapeutic or staging benefit for low risk patients.  A Mayo study revealed no data showing therapeutic benefit in high risk patients.  For clinically node negative high risk patients, there is staging value but no proven therapeutic benefit. Rate of positive nodes is associated with stage and grade; the higher the stage and grade, the more likely there will be positive nodes.  A tumor> 10 cm w...
Source: Kidney Cancer Association - November 29, 2011 Category: Urology & Nephrology Source Type: news